Table 4.
Liver histology according to the presence of metabolic syndrome in NASH cases (%)
| Liver histology |
Patients with NASH (n = 69) |
|
| With metabolic syndrome (n = 46, 66.6%) | Without metabolicsyndrome (n = 23, 33.4%) | |
| Fatty infiltration | ||
| Mild | 20 (43.4) | 11 (47.8) |
| Moderate | 19 (41.3) | 6 (26.1) |
| Severe | 7 (15.3) | 6 (26.1) |
| Necroinflammation | ||
| Absent | 0 (0) | 0 (0) |
| Mild | 13 (28.3) | 9 (39.1) |
| Moderate | 28 (60.9) | 13 (56.5) |
| Severe | 5 (10.8) | 1 (4.40) |
| Fibrosis | ||
| Absent | 20 (43.4) | 9 (39.1) |
| Perisinusoidal/pericellular | 16 (34.7) | 9 (39.1) |
| Periportal | 7 (15.4) | 2 (8.60) |
| Bridging | 3 (6.50) | 3 (13.2) |
| Cirrhosis | 1 (2.12) | 0 (0) |
Evaluations were performed using percentage values. Presence of metabolic syndrome seemed to increase the severity of steatosis, necroinflammation and fibrosis in liver, but these results were not significant as well.